Vancouver, British Columbia – November 27, 2018 – Harrys Manufacturing Inc. (CSE:HARY)  (“Harrys” or the “Company”), is pleased to announce it has developed a proprietary high throughput pre-roll technology and manufacturing process for use in the cannabis market.  Based on the existing process for rolling tobacco cigarettes, Harrys has adapted its current technology for potential use in the cannabis industry. Harrys is expecting to provide licensed producers in the cannabis space with the technology and capability to produce standardized, consistent and high-quality product that is packaged and private labelled to fit any demand.

“We are confident that our proprietary manufacturing process for pre-rolled cannabis cigarettes will provide a competitive opportunity for licensed producers looking to sell a high volume of quality cannabis cigarettes,” stated Kevin Kohanik, Harrys’ Chief Executive Officer. “With confidence in our proprietary process and current manufacturing capacity of 5 million tobacco cigarettes per week using our Molin Mark 8 manufacturing equipment and production line, we will be pursuing partnerships with leading producers that are eagerly interested in attaining leadership in this rapidly growing segment of the cannabis market. The Company is not licensed to produce cannabis cigarettes by Health Canada and any joint venture or licensing agreement to produce cannabis cigarettes using our proprietary manufacturing process and equipment will be subject to the applicable Health Canada regulations and permitting.”

About Harrys

Harrys Manufacturing generates revenues from the sales and distribution of affordable, high quality, organically grown tobacco cigarettes to international customers.  Harrys utilizes various types of tobacco and blend components from Canadian growers to satisfy customer demands and preferences for products that meet Health Canada standards.  The Company’s management team brings over 50 years of combined experience in the domestic and international tobacco industry.

ON BEHALF OF THE BOARD

“Kevin Kohanik”                        

Kevin Kohanik

Director and CEO

Telephone: 604-308-1602

For more information, please contact:

Glenn Little, Corporate Communications

Telephone: (604) 565-5100       

Email:                           

The CSE has neither approved nor disapproved the information contained herein.

This news release contains forward-looking statements. The Company has provided the forward-looking statements in reliance on assumptions that it believes are reasonable at this time including, without limitation, its ability to adapt its current technology for use in the cannabis industry. The reader is cautioned that the assumptions used in the preparation of the forward-looking statements may prove to be incorrect. All such forward-looking statements involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company’s control. Such risks and uncertainties include, without limitation: the Company’s inability to adapt its technology for use in the cannabis industry and the Company’s inability to generate revenues from the sales and distribution of cigarettes to international customers. The actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits, including the amount of proceeds, the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive.